Merck Wilmington Biotech Manufacturing Facility
Sector: Manufacturing (Industrial) • Location: Wilmington, Delaware, United States
Source: Site Selection Magazine
Merck has broken ground on a new $1 billion biotech manufacturing facility in Wilmington, Delaware, which will support the production of next-generation biologics and therapies, including the cancer treatment drug Keytruda. The facility is expected to create 500 new jobs, with potential for further expansion.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | Under Construction |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | Merck has broken ground on a new $1 billion biotech manufacturing facility in Wilmington, Delaware, which will support the production of next-generation biologics and therapies, including the cancer treatment drug Keytruda. The facility is expected to create 500 new jobs, with potential for further expansion. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |